EUVIMEDEUVIMED entdecken
Open Access

Direct microglia replacement reveals pathologic and therapeutic contributions of brain macrophages to a monogenic neurological disease

William H Aisenberg, Carleigh A O'Brien, Madison Sangster, Fazeela Yaqoob, Yuanchao Zhang, Brian Temsamrit, Searlait Thom, Luca Gosse, Sai Chaluvadi, Bilal Elfayomi, Gavin Lee, Vidhur Polam und 18 weitere

Immunity · 2025-05 · 58 (5) · 1254-1268.e9

DOI: 10.1016/j.immuni.2025.03.019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, 2025-05. Verfasst von William H Aisenberg und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Microglia, Macrophages, Brain, Leukodystrophy, Globoid Cell. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, NIDDK NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Krabbe disease, also named globoid cell (GC) leukodystrophy (GLD) for its distinct lipid-laden macrophages, is a severe leukodystrophy caused by galactosylceramidase (GALC) mutations. Hematopoietic stem cell transplant (HSCT) ameliorates disease and is associated with central nervous system (CNS) engraftment of GALC+ donor macrophages. Yet, the role of macrophages in GLD pathophysiology and HSCT remains unclear. Using single-cell sequencing, we revealed early interferon response signatures that preceded progressively severe macrophage dyshomeostasis and identified a molecular signature of GCs, which we validated in human brain specimens. Genetic depletion and direct microglia replacement by CNS monocyte injection rapidly replaced >80% of endogenous microglia with healthy macrophages in the twitcher (GalcW355∗) mouse model of GLD. Perinatal microglia replacement completely normalized transcriptional signatures, rescued histopathology, and doubled average survival. Overall, we uncovered distinct forms of microglial dysfunction and evidence that direct, CNS-limited microglia replacement improves a monogenic neurodegenerative disease, identifying a promising therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaMacrophagesBrainLeukodystrophy, Globoid CellAnimalsMiceHumansDisease Models, AnimalHematopoietic Stem Cell TransplantationGalactosylceramidaseMice, Inbred C57BLMutation

Stichwörter der Autor:innen

Krabbe diseasedisease-associated macrophagegloboid cellgloboid cell leukodystrophyhematopoietic stem cell transplantmicrogliamicroglia replacement

Substanzen

Galactosylceramidase

Autor:innen und Institutionen

  • Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Division of Neurology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Department of Biomedical Informatics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
  • Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Division of Neurology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Förderung

  • NIMH NIH HHS
  • NIDDK NIH HHS
  • NCI NIH HHS
  • NINDS NIH HHS
  • NIH HHS
  • Newcastle University
  • Alzheimer's Research Trust
  • National Institutes of Health

Zitieren

APA

Aisenberg, W. H., O'Brien, C. A., Sangster, M., Yaqoob, F., Zhang, Y., Temsamrit, B., Thom, S., Gosse, L., Chaluvadi, S., Elfayomi, B., Lee, G., Polam, V., Levitt, E. M., Liu, G., Lombroso, S. I., Nemec, K. M., Clowry, G., Nieves, C., Rawat, P., …, & Bennett, F. C. (2025). Direct microglia replacement reveals pathologic and therapeutic contributions of brain macrophages to a monogenic neurological disease. Immunity, 58(5), 1254-1268.e9. https://doi.org/10.1016/j.immuni.2025.03.019

Vancouver

Aisenberg WH, O'Brien CA, Sangster M, Yaqoob F, Zhang Y, Temsamrit B, et al. Direct microglia replacement reveals pathologic and therapeutic contributions of brain macrophages to a monogenic neurological disease. Immunity. 2025;58(5):1254-1268.e9. doi:10.1016/j.immuni.2025.03.019

BibTeX
@article{Aisenberg2025,
  author = {Aisenberg, William H and O'Brien, Carleigh A and Sangster, Madison and Yaqoob, Fazeela and Zhang, Yuanchao and Temsamrit, Brian and Thom, Searlait and Gosse, Luca and Chaluvadi, Sai and Elfayomi, Bilal and Lee, Gavin and Polam, Vidhur and Levitt, Eli M and Liu, Gary and Lombroso, Sonia I and Nemec, Kelsey M and Clowry, Gavin and Nieves, Cassaundra and Rawat, Priyanka and Church, Emily and Martinez, Daniel and Shoffler, Clarissa and Kancheva, Daliya and Petucci, Christopher and Taylor, Deanne and Kofler, Julia and Erskine, Daniel and Movahedi, Kiavash and Bennett, Mariko L and Bennett, F Chris},
  title = {Direct microglia replacement reveals pathologic and therapeutic contributions of brain macrophages to a monogenic neurological disease},
  journal = {Immunity},
  year = {2025},
  volume = {58},
  number = {5},
  pages = {1254--1268.e9},
  doi = {10.1016/j.immuni.2025.03.019}
}
Kostenlos starten →